Terence R. Flotte, MD

Created by students in 2021, UMass LIGHT aims to increase diversity, equity and inclusion; promote career growth; and create professional development opportunities through mentorship and community events.

The 2022 UMass Chan Medical School Educational Recognition Awards celebration was held on Tuesday, April 26 to honor achievement by faculty of all three schools. The recipient of the Chancellor’s Award for Excellence in Mentoring was named and Pang-Yen Fan, MD, delivered the honorary Last Lecture.

U.S. News & World Report ranked the T.H. Chan School of Medicine 10th for primary care education in its 2023 rankings of America’s best graduate schools. UMass Chan also ranks in the top 50 for research and Doctor of Nursing Practice programs.

UMass Chan Medical School will use a $2 million grant from the Baker-Polito administration and the Massachusetts Life Sciences Center to acquire a super-resolution microscope that can detect, track and investigate viruses of pandemic potential.

An Oregon couple whose baby was diagnosed with an ultra-rare genetic disorder has launched a foundation to raise money to accelerate development of therapies for the condition and recently signed a gift agreement with UMass Chan Medical School to jump start the research.

The Translational Institute for Molecular Therapeutics leverages UMass Chan Medical School’s extensive experience in researching and developing gene therapies for early-stage clinical trials. Miguel Sena-Esteves, PhD, is director of the new institute.

Researchers from UMass Chan Medical School have received a five-year $13.6 million program project grant from the National Heart, Lung and Blood Institute to develop new gene therapy models for alpha-1 antitrypsin deficiency, a chronic, debilitating genetic lung disease that shortens the lifespan.

UMass Chan Medical School welcomed 36 School of Medicine students into the Delta chapter of the Alpha Omega Alpha Honor Medical Society during an induction ceremony on Wednesday, Oct. 20.

Riaan Research Initiative, a non-profit organization, and UMass Chan Medical School are entering into an agreement to fund, research and develop a gene replacement therapy to combat Cockayne syndrome, a fatal autosomal recessive disorder.

Chancellor Michael F. Collins told the 162-member School of Medicine Class of 2025 that each encounter the future MDs have with their patients will be unique and profound.